Impact of Clinical Pharmacist Consultations on Postoperative Pain in Ambulatory Surgery

Int J Environ Res Public Health. 2023 Feb 23;20(5):3967. doi: 10.3390/ijerph20053967.

Abstract

Post-operative pain is a common symptom of ambulatory surgery. The objective of this study was to evaluate a pain management protocol integrating a pharmacist consultation. We conducted a quasi-experimental, single center, before-after study. The control group was recruited between 1 March and 31 May 2018 and the intervention group between 1 March and 31 May 2019. Outpatients in the intervention group received a pharmacist consultation, in addition to the usual anesthesiologist and nurse consultations. Pharmacist consultations were conducted in two steps: the first step consisted of general open-ended questions and the second step of a specific and individualized pharmaceutical interview. A total of 125 outpatients were included in each group. There were 17% (95% CI 5 to 27%, p = 0.022) fewer patients with moderate to severe pain in the pharmaceutical intervention group compared with the control group, which corresponded to a decrease in the mean pain level of 0.9/10 (95% CI -1.5/10; -0.3/10; p = 0.002). The multivariate analysis did not reveal any confounding factors, showing that only the pharmaceutical intervention could explain this result. This study demonstrates a positive impact of pharmacist consultations on postoperative pain in ambulatory surgery.

Keywords: ambulatory surgery; city-hospital link; health care; patient pathway; pharmaceutical care; pharmaceutical interviews; post-operative pain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ambulatory Surgical Procedures*
  • Humans
  • Pain, Postoperative
  • Pharmaceutical Preparations
  • Pharmacists*
  • Referral and Consultation

Substances

  • Pharmaceutical Preparations

Grants and funding

This research received a “Year of Research” grant awarded jointly by the Normandy Regional Health Agency, the Charles Nicolle Foundation, and the Interregional Group for Clinical Research and Innovation of Northwest France. This funding allowed us to pay the pharmacist for the realization of the pharmaceutical interviews.